Nylim GBL Ety R&D LDR ETF-UiWRNDETF

13F holders, Q1 2026 (March 31)
4holders +3
3new positions
0sold out
$35.86avg. 13F price*

At the end of Q1 2026, 4 institutions reported holding Nylim GBL Ety R&D LDR ETF-Ui (WRND) in their 13F filings, up 3 from Q4 2025. 3 opened new positions and 0 sold out. The largest holders were New York Life Investment Management LLC ($6.8M), GTS Securities LLC ($629K) and Ameritas Investment Partners, Inc. ($2K).

Company
Nylim GBL Ety R&D LDR ETF-Ui
Filed as
NEW YORK LIFE INVESTMENTS ET (Q1 2026)
CUSIP
45409B255
Latest filing quarter
Q2 2026

History

Number of 13F holders

012345 Q1 2024: 4Q1 2024Q2 2024: 4Q2 2024Q3 2024: 4Q3 2024Q4 2024: 4Q4 2024Q1 2025: 3Q1 2025Q2 2025: 3Q2 2025Q3 2025: 3Q3 2025Q4 2025: 1Q4 2025Q1 2026: 4Q1 2026Q2 2026: 5Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions3$631K
Exits0$0

All 13F filers, Q4 2025 → Q1 2026: 17,593 shares bought, net +17,593 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 4 holders

New York Life Investment Management LLC 0.06% No change 190,000 $6.8M
GTS Securities LLC 0.02% New 17,529 $629K
Ameritas Investment Partners, Inc. 0.00% New 63 $2K
Morgan Stanley 0.00% New 1 $36

"% of holder's portfolio" is WRND's weight in each manager's 13F, not the share of Nylim GBL Ety R&D LDR ETF-Ui the manager owns.